Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

MERCAPTOPURINE vs MEROPENEM ANHYDROUS: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

MERCAPTOPURINE vs MEROPENEM ANHYDROUS: Safety Overview

Metric MERCAPTOPURINE MEROPENEM ANHYDROUS
Total FAERS Reports 11,490 144
Deaths Reported 1,468 25
Death Rate 12.8% 17.4%
Hospitalizations 5,925 102
Average Patient Age 21.5 yrs 55.0 yrs
% Female Patients 43.8% 44.2%
FDA Approval Date Approved Prior to Jan 1, 1982 N/A
Manufacturer Florida Pharmaceutical Products, LLC Mylan Institutional LLC
Route ORAL INTRAVENOUS
Marketing Status Prescription N/A